165 related articles for article (PubMed ID: 20979607)
1. Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.
Huang L; Liao LM; Wang HY; Zheng M
BMC Cancer; 2010 Oct; 10():585. PubMed ID: 20979607
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Atypia Is a Necessary Factor for Diagnosis of Primary Ovarian Fibrosarcoma: A Case Report and Literature Review.
Zhang Z; Yao A; Xin Q; Shi Y; Zhang A
Gynecol Obstet Invest; 2020; 85(5):437-445. PubMed ID: 33011729
[TBL] [Abstract][Full Text] [Related]
3. Primary ovarian fibrosarcoma with long-term survival: a report of two cases.
Choi WJ; Ha MT; Shin JK; Lee JH
J Obstet Gynaecol Res; 2006 Oct; 32(5):524-8. PubMed ID: 16984523
[TBL] [Abstract][Full Text] [Related]
4. Primary ovarian fibrosarcoma: a case report and review of the literature.
Ozdemır O; Sarı ME; Sen E; Ilgın BU; Gurescı S; Atalay CR
J Exp Ther Oncol; 2016 Jul; 11(3):225-235. PubMed ID: 28471131
[TBL] [Abstract][Full Text] [Related]
5. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
[TBL] [Abstract][Full Text] [Related]
6. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
7. Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma.
Irving JA; Alkushi A; Young RH; Clement PB
Am J Surg Pathol; 2006 Aug; 30(8):929-38. PubMed ID: 16861962
[TBL] [Abstract][Full Text] [Related]
8. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
9. Ovarian fibrosarcoma: A single-institution experience and a review of the literature.
Sun TT; Cheng NH; Cao DY; Peng P
J Ovarian Res; 2020 Dec; 13(1):142. PubMed ID: 33292402
[TBL] [Abstract][Full Text] [Related]
10. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
Aune G; Stunes AK; Tingulstad S; Salvesen O; Syversen U; Torp SH
Int J Clin Exp Pathol; 2011 Jun; 4(5):444-53. PubMed ID: 21738816
[TBL] [Abstract][Full Text] [Related]
11. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
12. Ovarian fibrosarcoma with five-year survival: a case report.
Cinel L; Taner D; Nabaei SB; Oguz S; Gökmen O
Eur J Gynaecol Oncol; 2002; 23(4):345-6. PubMed ID: 12214741
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
15. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
16. Ovarian fibrosarcoma with long-term survival: a case report.
Huang YC; Hsu KF; Chou CY; Dai YC; Tzeng CC
Int J Gynecol Cancer; 2001; 11(4):331-3. PubMed ID: 11520377
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
20. [Mitotically active cellular fibroma of ovary: a clinicopathologic analysis].
Bi R; Zhao Y; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):660-4. PubMed ID: 24433727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
